![Gabriel Hortobagyi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gabriel Hortobagyi
Nessuna posizione attualmente
Profilo
Gabriel N.
Hortobagyi served as President of the American Society of Clinical Oncology, Inc. in 2007 and as Director of the Conquer Cancer Foundation of the American Society of Clinical in 2011.
He holds an MBA from Rice University and a graduate degree from Texas A&M University.
Precedenti posizioni note di Gabriel Hortobagyi
Società | Posizione | Fine |
---|---|---|
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Presidente | 01/01/2007 |
Conquer Cancer Foundation of the American Society of Clinical
![]() Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Direttore/Membro del Consiglio | - |
Formazione di Gabriel Hortobagyi
Texas A&M University | Graduate Degree |
Rice University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Conquer Cancer Foundation of the American Society of Clinical
![]() Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Commercial Services |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
- Borsa valori
- Insiders
- Gabriel Hortobagyi